[1] Ju X, Bai J, She Y, et al.Symptom cluster trajectories and sentinel symptoms during the first cycle of chemotherapy in patients with lung cancer[J]. Eur J Oncol Nurs, 2023, 63: 102282. DOI:10.1016/j.ejon.2023.102282.
[2] Barsevick AM, Whitmer K, Nail LM, et al.Symptom cluster research: conceptual, design, measurement, and analysis issues[J]. J Pain Symptom Manage, 2006, 31(1): 85-95. DOI:10.1016/j.jpainsymman.2005.05.015.
[3] Molassiotis A, Wengstrom Y, Kearney N.Symptom cluster patterns during the first year after diagnosis with cancer[J]. J Pain Symptom Manage, 2010, 39(5): 847-858. DOI:10.1016/j.jpainsymman.2009.09.012.
[4] Skerman HM, Yates PM, Battistutta D.Cancer-related symptom clusters for symptom management in outpatients after commencing adjuvant chemotherapy, at 6 months, and 12 months[J]. Support Care Cancer, 2012, 20(1): 95-105. DOI:10.1007/s00520-010-1070-z.
[5] Dodd M, Janson S, Facione N, et al.Advancing the science of symptom management[J]. J Adv Nurs, 2001, 33(5): 668-676. DOI:10.1046/j.1365-2648.2001.01697.x.
[6] Miaskowski C, Dodd M, Lee K.Symptom clusters: the new frontier in symptom management research[J]. J Natl Cancer Inst Monogr, 2004, (32): 17-21. DOI:10.1093/jncimonographs/lgh023.
[7] Kim HJ, Mcguire DB, Tulman L, et al.Symptom clusters: concept analysis and clinical implications for cancer nursing[J]. Cancer Nurs, 2005, 28(4): 270-282. DOI:10.1097/00002820-200507000-00005.
[8] Brown J K, Cooley M E, Chernecky C, et al.A symptom cluster and sentinel symptom experienced by women with lung cancer[J]. Oncol Nurs Forum, 2011, 38(6): 425-435. DOI:10.1188/11.ONF.E425-E435.
[9] Aktas A.Cancer symptom clusters: current concepts and controversies[J]. Curr Opin Support Palliat Care, 2013, 7(1): 38-44. DOI:10.1097/SPC.0b013e32835def5b.
[10] 马景双, 王爱平. 肺癌术后化疗患者症状群及前哨症状的调查[J]. 护理学报, 2021, 28(12): 33-37. DOI:10.16460/j.issn1008-9969.2021.12.033.
[11] Rha SY, Park M, Lee J.Stability of symptom clusters and sentinel symptoms during the first two cycles of adjuvant chemotherapy[J]. Support Care Cancer, 2019, 27(5): 1687-1695. DOI:10.1007/s00520-018-4413-9.
[12] 苏晓雨, 张瑞丽, 王青青, 等. 癌症患者症状群概述及识别方法的研究进展[J]. 护理实践与研究, 2023, 20(8): 1151-1155. DOI:10.3969/j.issn.1672-9676.2023.08.009.
[13] Jones PJ, Ma R, Mcnally RJ.Bridge centrality: c network approach to understanding comorbidity[J]. Multivariate Behav Res,2021,56(2):353-367. DOI:10.1080/00273171.2019.1614898.
[14] Nilsberth C, Sackmann V, Fransson K, et al.Symptom clusters in palliative-stage cancer correlate with proinflammatory cytokine cluster[J]. Ann Palliat Med, 2023, 12(3): 458-471. DOI:10.21037/apm-22-974.
[15] Harris CS, Miaskowski CA, Conley YP, et al.Epigenetic regulation of inflammatory mechanisms and a psychological symptom cluster in patients receiving chemotherapy[J]. Nurs Res, 2023,72(3):200-210.DOI:10.1097/NNR.0000000000000643.
[16] 童欢欢. 肺癌患者化疗期症状群及其与生活质量、炎症标志物的相关性研究[D]. 合肥:安徽医科大学,2021. DOI:10.26921/d.cnki.ganyu.2021.000652.
[17] 王玉栋, 陈红姗, 单玉洁, 等. 晚期肺癌患者癌症相关性疲乏的发生及其与血清炎性因子的关系[J]. 肿瘤防治研究, 2015, 42(6): 576-581. DOI:10.3971/j.issn.1000-8578.2015.06.010.
[18] Myers JS.Proinflammatory cytokines and sickness behavior: implications for depression and cancer-related symptoms[J]. Oncol Nurs Forum,2008, 35(5): 802-807.DOI:10.1188/08.ONF.802-807.
[19] 张娟芳, 汪欢, 张思思, 等. 肺癌化疗患者症状群研究的范围综述[J]. 护理进修杂志, 2025, 40(2): 190-197. DOI:10.16821/j.cnki.hsjx.2025.02.015.
[20] Li N, Wu J, Zhou J, et al.Symptom clusters change over time in patients with lung cancer during perichemotherapy[J]. Cancer Nurs, 2021, 44(4):272-280. DOI:10.1097/NCC.0000000000000787.
[21] 谌欣欣, 刘国凤, 杨英姿, 等. 肺癌化疗患者住院期间体力活动水平和症状群的相关性分析[J]. 结核与肺部疾病杂志, 2024, 5(3): 197-206. DOI:10.19983/j.issn.2096-8493.2024048.
[22] 李楠楠, 吴静, 徐敏, 等. 肺癌化疗患者症状群及影响因素分析[J]. 护士进修杂志, 2018, 33(22): 2029-2032. DOI:10.16821/j.cnki.hsjx.2018.22.004.
[23] 李楠楠, 陈芬荣, 朱惠瑛, 等. 肺癌患者化疗前后症状群的调查研究[J]. 解放军护理杂志, 2017, 34(23): 34-38. DOI:10.3969/j.issn.1008-9993.2017.23.008.
[24] 傅郭妹芝, 苏文敏, 章立楠, 等. 肺癌患者化疗期间症状群的动态研究[J]. 浙江临床医学, 2022, 24(11): 1658-1661.
[25] 马景双, 许辉, 刘姗, 等. 肺癌术后病人化疗初期症状群内前哨症状的调查[J]. 护理研究, 2022, 36(19): 3528-3533. DOI:10.12102/j.issn.1009-6493.2022.19.029.
[26] Rha SY, Lee J.Stable symptom clusters and evolving symptom networks in relation to chemotherapy cycles[J]. J Pain Symptom Manage, 2021, 61(3): 544-554. DOI:10.1016/j.jpainsymman.2020.08.008.
[27] 叶艳欣, 秦岚, 骆佳慧, 等. 肺癌患者化疗相关症状群的发生现状及影响因素分析[J]. 中华护理杂志, 2023, 58(18): 2230-2238. DOI: 10.3761/j.issn.0254-1769.2023.18.008.
[28] Harris CS, Dodd M, Kober K M, et al.Advances in conceptual and methodological issues in symptom cluster research: a 20-year perspective[J]. ANS Adv Nurs Sci, 2022, 45(4): 309-322. DOI:10.1097/ANS.0000000000000423.
[29] Epskamp S, Borkulo CDV, Veen DCVD, et al.Personalized Network Modeling in psychopathology: the importance of contemporaneous and temporal connections[J]. Clin Psychol Sci, 2018, 6(3):416-427.DOI:10.1177/2167702617744325. Epub 2018 Jan 19.
[30] David SJ, Marshall AJ, Evanovich EK, et al.Intraindividual Dynamic Network Analysis - implications for clinical assessment[J]. J Psychopathol Behav Assess, 2018, 40(2): 235-248. DOI:10.1007/s10862-017-9632-8.
[31] 杨中方, 金依霖,何加敏,等. 基于数据类型的症状网络分类:同期网络动态网络和个体化网络[J]. 护理进修杂志, 2023, 38(24): 2219-2224. DOI:10.16821/j.cnki.hsjx.2023.24.003.
[32] Zhu Z, Sun Y, Kuang Y, et al.Contemporaneous symptom networks of multidimensional symptom experiences in cancer survivors: a network analysis[J]. Cancer Med, 2023, 12(1): 663-673. DOI:10.1002/cam4.4904.
[33] Cleeland CS, Mendoza TR, Wang XS, et al. Assessing symptom distress in cancer patients: The M. D. Anderson Symptom Inventory[J]. Cancer, 2000, 89(7): 1634-1646. DOI:10.1002/1097-0142(20001001)89:7<1634::aid-cncr29>3.0.co;2-v.
[34] Mendoza TR, Wang XS, Lu C, et al.Measuring the symptom burden of lung cancer: the validity and utility of the lung cancer module of the M. D. Anderson Symptom Inventory[J]. Oncologist, 2011, 16(2): 217-227. DOI:10.1634/theoncologist.2010-0193.
[35] Portenoy RK, Thaler HT, Kornblith AB, et al.The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress[J]. Eur J Cancer, 1994, 30A(9): 1326-1336. DOI:10.1016/0959-8049(94)90182-1.
[36] Reeve BB, Mitchell SA, Dueck AC, et al.Recommended patient-reported core set of symptoms to measure in adult cancer treatment trials[J]. J Natl Cancer Inst, 2014, 106(7). DOI:10.1093/jnci/dju129.
[37] Russell J, Wong ML, Mackin L, et al.Stability of symptom clusters in patients with lung cancer receiving chemotherapy[J]. J Pain Symptom Manage, 2019, 57(5): 909-922. DOI:10.1016/j.jpainsymman.2019.02.002.
[38] Wang D, Fu J.Symptom clusters and quality of life in China patients with lung cancer undergoing chemotherapy[J]. Afr Health Sci, 2014, 14(1): 49-55. DOI:10.4314/ahs.v14i1.8.
[39] Luo Y, Zhang L, Mao D, et al.Symptom clusters and impact on quality of life in lung cancer patients undergoing chemotherapy[J]. Qual Life Res, 2024, 33(12): 3363-3375. DOI:10.1007/s11136-024-03778-x.
[40] Ma J, Xu H, Liu S, et al.An investigation of symptom clusters and sentinel symptoms during the first 2 cycles of postoperative chemotherapy in patients with lung cancer[J]. Cancer Nursing,2022,45(6):488-496.DOI:10.1097/ncc.0000000000001058.
[41] Silvoniemi M, Vasankari T, Löyttyniemi E, et al.Symptom assessment for patients with non-small cell lung cancer scheduled for chemotherapy[J]. Anticancer Res, 2016, 36(8): 4123-4128.
[42] Singh K, Kober KM, Paul SM, et al.Gastrointestinal symptoms are associated with trajectories of chemotherapy-induced nausea[J]. Support Care Cancer, 2020, 28(5): 2205-2215. DOI:10.1007/s00520-019-05031-5.
[43] Zhang Y, Chen YC, Hu L, et al.Chemotherapy-induced functional changes of the default mode network in patients with lung cancer[J]. Brain Imaging Behav, 2020, 14(3): 847-856. DOI:10.1007/s11682-018-0030-y.
[44] Wong ML, Cooper BA, Paul SM, et al.Differences in symptom clusters identified using ratings of symptom occurrence vs. severity in lung cancer patients receiving chemotherapy[J]. J Pain Symptom Manage, 2017, 54(2): 194-203. DOI:10.1016/j.jpainsymman.2017.04.005.
[45] 何瑞仙, 王艳, 苏伟才, 等. 铂类化疗药物治疗肺癌患者症状簇的调查研究[J]. 中国肿瘤临床与康复, 2019, 26(1): 9-13. DOI:10.13455/j.cnki.cjcor.2019.01.03.
[46] 王艳, 何瑞仙, 黄秀秀, 等. 1631例肺癌化疗患者症状簇的调查分析[J]. 中国肿瘤临床与康复, 2021, 28(2): 138-143. DOI:10.13455/j.cnki.cjcor.2021.02.03.
[47] Teng L, Zhou Z, Yang Y, et al.Identifying central symptom clusters and correlates in patients with lung cancer post-chemotherapy: a network analysis[J]. Asia Pac J Oncol Nurs, 2024, 11(4):100383. DOI:10.1016/j.apjon.2024.100383.
[48] Luo Y, Mao D, Zhang L, et al.Identification of symptom clusters and sentinel symptoms during the firstcycle of chemotherapy in patients with lung cancer[J]. Support Care Cancer, 2024, 32(6): 385. DOI:10.1007/s00520-024-08600-5.
[49] Luo Y, Luo J, Su Q, et al.Exploring central and bridge symptoms in patients with lung cancer: a network analysis[J]. Semin Oncol Nurs, 2024, 40(3): 151651. DOI:10.1016/j.soncn.2024.151651.
[50] Miaskowski C, Barsevick A, Berger A, et al.Advancing symptom science through symptom cluster research: expert panel proceedings and recommendations[J]. J Natl Cancer Inst, 2017, 109(4). DOI:10.1093/jnci/djw253.
[51] 马景双, 王爱平, 王艳杰, 等. 基于前哨症状的肺癌术后化疗患者护理干预方案的构建及应用[J]. 中华护理杂志, 2024, 59(2): 133-141. DOI: 10.3761/j.issn.0254-1769.2024.02.001.
[52] 郑小敏, 万笑. 症状管理教育对肺癌化疗患者核心症状群的改善效果[J]. 护理实践与研究, 2020, 17(6): 47-49. DOI:10.3969/j.issn.1672-9676.2020.06.018.
[53] 姜瑞娟, 王月霞. 基于消化道症状群的针对性护理方案在肺癌根治术后化疗患者中的应用效果[J]. 黑龙江医药科学, 2025, 48(3): 138-140.
[54] 林丹萍, 王丽红, 罗晓华. 多模态运动联合正念冥想应用于肺癌化疗患者的效果分析[J]. 医学理论与实践, 2023, 36(23): 4111-4114. DOI: 10.19381/j.issn.1001-7585.2023.23.059.
[55] 刘华征, 侯振华. 健康信念模式联合正念减压干预对肺癌化疗患者希望水平及癌因性疲乏的影响[J]. 当代护士(中旬刊), 2023, 30(7): 91-94. DOI:10.19792/j.cnki.1006-6411.2023.20.022.
[56] 张丹, 李红杰, 赵勇, 等. 分阶段认知行为干预在非小细胞肺癌化疗患者中的应用效果[J]. 癌症进展, 2024, 22(4): 431-434. DOI: 10.11877/j.issn.1672-1535.2024.22.04.20.
[57] 饶菊芳, 罗梅花. 叙事护理在晚期非小细胞肺癌化疗患者中的应用效果研究[J]. 当代护士(下旬刊), 2021, 28(12): 115-117. DOI: 10.19793/j.cnki.1006-6411.2021.36.039.
[58] Cheung DST, Takemura N, Lam TC, et al.Feasibility of Aerobic Exercise and Tai-Chi Interventions in advanced lung cancer patients: a randomized controlled trial[J]. Integr Cancer Ther, 2021, 20:15347354211033352. DOI:10.1177/15347354211033352.
[59] Molassiotis A, Vu D, Ching SSY.The effectiveness of Qigong in managing a cluster of symptoms (Breathlessness- Fatigue-Anxiety) in patients with lung cancer: a randomized controlled trial[J]. Integr Cancer Ther, 2021, 20: 1-12. DOI:10.1177/15347354211008253.
[60] 赵琳琳, 郭华, 李辉辉, 等. 基于PERMA模式下听觉运动训练对肺癌首次化疗患者间歇期心理状态、症状群及癌因性疲乏的影响[J]. 航空航天医学杂志, 2024, 35(6): 731-734. DOI:10.3969/j.issn.2095-1434.2024.06.032.
[61] 李慧锋, 徐凯佳, 贾芳芳, 等. Tomatis高低频转换听觉—运动训练对肺癌同步放化疗期患者症状群管理与感知控制的影响[J]. 护理实践与研究, 2021, 18(4): 583-585. DOI:10.3969/j.issn.1672-9676.2021.04.031.
[62] Chen HM, Tsai CM, Wu YC, et al.Randomised controlled trial on the effectiveness of home-based walking exercise on anxiety, depression and cancer-related symptoms in patients with lung cancer[J]. Br J Cancer, 2015, 112(3): 438-445. DOI:10.1038/bjc.2014.612.
[63] 何盈蓉,许陶,余静娟,等.中医技术护理在缓解肺癌化疗期间患者恶心呕吐反应中的应用[J]. 齐鲁护理杂志, 2022, 28(3):92-94.DOI:10.3969/j.issn.1006-7256.2022.03.028.
[64] 焦杰,罗志芹,强万敏.穴位按摩在晚期癌症患者症状群中的应用效果研究[J]. 护士进修杂志, 2015, 30(24): 2221-2223. DOI:10.16821/j.cnki.hsjx.2015.24.005.
[65] 林梅香,黄丽华,黄冬梅,等.基于病房-门诊-社区管理模式的耳穴埋豆对肺癌失眠患者化疗间歇期症状群的影响[J]. 中国医药导报, 2024, 21(36): 178-182. DOI:10.20047/j.issn1673-7210.2024.36.33.
[66] Zhang CX, Bu MR, Wu XM, et al.Efficacy of acupuncture for a cough-related symptom cluster in patients with lung cancer: a randomized controlled trial[J]. Eur J Oncol Nurs, 2024, 70: 102598. DOI:10.1016/j.ejon.2024.102598.